An At-Home Coronavirus Test May Be On the Way in the U.S.
As cases of COVID-19 continue to climb in the U.S., there’s a new urgency to make sure there are as many tests as possible to diagnose people who have symptoms that might indicate an infection. Knowing if people are positive is important for guiding their next steps: self-isolation, avoiding contact with others, and, if their symptoms get worse, seeking medical care. To date, access to tests has been spotty at best across the country, and while more kits are now available than even a week ago, most are gene-based assays that take several days for commercial labs to process and produce results. That may change in about two months if the Food and Drug Administration (FDA) gives Emergency Use Authorization to the first blood-based COVID-19 test in the U.S. Scanwell Health, an at-home test company based in California, licensed the rights to a test developed by Chinese company Innovita, which was used extensively at the height of country’s epidemic earlier this year. “The advantage of a rapid test like we’re working on is that it can be performed completely at home by the patient,” says Dr. Jack Jeng, chief medical officer of Scanwell. “It can be widely scalable rapidly and quickly deployed.” That’s critical during an unfolding pandemic. In China, the test was approved by China’s Centers for Disease Control, and helped public health officials to keep pace with the burgeoning number of cases in Wuhan, at a time when gene-based ...
Citing "continuing uncertainty created by the COVID-19 pandemic," the board that oversees the University of Arkansas' Arkansas Business Hall of Fame says it won't induct a new class of honorees in 2021.
Publication date: Available online 23 September 2020Source: Research in Developmental DisabilitiesAuthor(s): Matilde Taddei, Sara Bulgheroni
CONCLUSIONS: YHPG has significant antiviral effects in IFV-infected mice, partially by inhibiting influenza virus replication and regulating the occurrence of apoptosis induced by influenza virus infection, suggesting that YHPG may be a promising antiviral agent with potential clinical application prospects. PMID: 32962483 [PubMed - as supplied by publisher]
Authors: Lam PH, Hon KL, Leung K, Leong KF, Li CK, Leung TF Abstract BACKGROUND: Atopic eczema (AE) is a common relapsing inflammatory skin disease in children which is often associated with chronicity and poor quality of life. Unlike atopic asthma, control of AE is seldom assessed in therapeutics. AIM: To investigate the utility of a Traffic Light Control (TLC) system as a measurement/assessment of self-perceived eczema control. METHODS: This is a prospectively study of all Chinese children (aged 6 to 18 years old) with eczema attending the paediatric dermatology clinic of a tertiary hospital from Jan to J...
Publication date: Available online 23 September 2020Source: CellAuthor(s): Jakob Kreye, S. Momsen Reincke, Hans-Christian Kornau, Elisa Sánchez-Sendin, Victor Max Corman, Hejun Liu, Meng Yuan, Nicholas C. Wu, Xueyong Zhu, Chang-Chun D. Lee, Jakob Trimpert, Markus Höltje, Kristina Dietert, Laura Stöffler, Niels von Wardenburg, Scott van Hoof, Marie A. Homeyer, Julius Hoffmann, Azza Abdelgawad, Achim D. Gruber
Authors: Thien F, Davies JM, Hew M, Douglass JA, O'Hehir RE Abstract INTRODUCTION: Epidemic thunderstorm asthma (ETSA) is due to a complex interaction of environmental and individual susceptibility factors, with outbreaks reported globally over the last four decades. Australia has been particularly susceptible with nearly half of episodes reported internationally, culminating in the catastrophic Melbourne 2016 event. AREAS COVERED: This narrative review focuses on primary research articles on thunderstorm asthma published since 2017 and relevant historical studies. Reported ETSA episodes are reviewed for common...
CONCLUSIONS: The validity of ICD-10 codes for cirrhosis, oesophageal varices and HCC is high. However, coding for ascites should be combined with a code of chronic liver disease to have an acceptable validity. PMID: 32960654 [PubMed - as supplied by publisher]
Conclusion: Mitigation of these effects by identifying subjects at risk and promoting dopaminergic homeostasis to help regulate stress-relative hypodopaminergia, attenuate fears, and prevent subsequent unwanted drug and non-drug RDS type addictive behaviors seems prudent. PMID: 32957797 [PubMed - as supplied by publisher]
NIH investigator co-led international research effort.
CONCLUSIONS: The COVID-19-related emergency condition had a highly negative impact on dental practices in Italy. Those who completed the survey reported practice closure or reduction during the lockdown, and a high level of concern about the professional future for all dental practitioners. Concerns related to professional activity were accompanied by severe anxiety levels. PMID: 32960524 [PubMed - as supplied by publisher]
More News: China Health | Coronavirus | Cough | COVID-19 | Emergency Medicine | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Genetics | Government | Health | Hospitals | Intensive Care | International Medicine & Public Health | Outbreaks | Pandemics | PET Scan | Pregnancy | Urinary Tract Infections